Clinical Trials Logo

Filter by:
NCT ID: NCT05601102 Completed - Quality of Life Clinical Trials

danceSing Care Evaluation: Testing the Effectiveness

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

This pilot randomised controlled trial aims to compare the effectiveness of a 12-week music and movement intervention in older adults in care homes compared to a waitlist control group. The main questions it aims to answer are: - Do salivary cortisol and DHEAS levels improve after the intervention, compared to the waitlist control group? - Do feelings of anxiety and depression improve after the intervention, compared to the waitlist control group? - Does the quality of life improve after the intervention, compared to the waitlist control group? - Does physical function improve after the intervention, compared to the waitlist control group? Participants will engage in music and movement sessions three times per week for 12 weeks. Researchers will compare the intervention group to the waitlist control group to see if any effects occur.

NCT ID: NCT05600452 Completed - Heat Stress Clinical Trials

Comparison of a Novel Condensed Heat Acclimation Programme With a Traditional Longer-term Heat Acclimation Programme

Start date: January 17, 2020
Phase: N/A
Study type: Interventional

Repeated exposure to heat in a laboratory setting (acclimation) elicits a range of adaptations, which reduce heat illness risk and increase work capacity in the heat. Traditional approaches to heat acclimation require daily heat exposures of 1 to 2 hours over ~7 to 10 consecutive days. Heat acclimation approaches which reduce the number of days to achieve acclimation may have utility. The primary purpose of the proposed research is to determine whether it is possible to achieve a similar degree of heat acclimation to that seen with a traditional longer-term heat acclimation approach by increasing the frequency of heat exposure, utilising multiple daily heat exposures over a smaller number of days. Secondary aims of the research are to examine whether heat acclimation provides cross-adaptation to a hypoxic stressor and whether heat acclimation improves aerobic fitness.

NCT ID: NCT05599529 Completed - COVID-19 Clinical Trials

A Retrospective Cohort Study of Differential Attainment, COVID-19 and Chaos

Start date: September 1, 2022
Phase:
Study type: Observational

A retrospective cohort study of Differential Attainment, COVID and Chaos: taking the difference out of a terrible trinity

NCT ID: NCT05599451 Completed - Smoking Clinical Trials

Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS

Start date: November 16, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled, open-label, 4 parallel arm study with a stratified randomization by sex (a quota for each sex [females and males] of at least 40% overall). This study aims to demonstrate the reduction of Biomarkers of Exposure (BoExp) to selected Harmful and Potentially Harmful Constituents (HPHC) in smokers switching from cigarettes (CIG) to each of the Tobacco Heating System (THS) variants with different heating technology (Blade device, Induction Mono device, or Induction Mid device, respectively), compared with smokers who continue to smoke CIG. A reduction of exposure to HPHC is expected in CIG smokers when switching completely to THS.

NCT ID: NCT05594329 Completed - Cognitive Change Clinical Trials

Neurological, Inflammatory and Metabolic Effects of Acute Mushroom Intervention in Older Adults

OYSACO
Start date: August 15, 2022
Phase: N/A
Study type: Interventional

This randomized crossover trial (RCT) investigates the acute effect (over a 6-hour period) of a meal containing varying serving sizes (doses) of freeze-dried oyster mushroom powder, on the cognitive behaviour and markers of metabolism and inflammation related to neuronal health in healthy adults aged 60-80 years old. The study will involve a screening visit and four testing visits, with a week interval between each. During the four testing visits, cognitive-mood battery tests will be taken at baseline and then at 2-, 4- and 6-hour intervals following the consumption of the intervention meal. Also, a blood draw will be taken at the end of each testing visit day to allow the determination of inflammatory, metabolic and neuronal markers.

NCT ID: NCT05593926 Completed - Pre-diabetes Clinical Trials

Fibre suppLements fOR Pre-diAbetes - An Assessment Oral Fibre Supplements on Pre-diabetes Outcome Measures

FLORA
Start date: November 16, 2022
Phase: N/A
Study type: Interventional

This trial will investigate whether a powdered fibre mix helps maintain healthy blood glucose levels in participants with pre-diabetes, where high blood sugar is a risk of diabetes.

NCT ID: NCT05591573 Completed - Cognitive Function Clinical Trials

The Impact of Glycemic Index on Sleep and Memory Consolidation

Start date: December 31, 2022
Phase: N/A
Study type: Interventional

The study will test whether the consumption of a low versus a high glycemic index pre-bed drink influences sleep architecture, memory consolidation, nocturnal glucose metabolism, and mood.

NCT ID: NCT05590754 Completed - Muscle Atrophy Clinical Trials

50% Body Weight Reverses Stature, Lumbar Disc Expansion and Vertebral Compliance by Hyper-Buoyancy Floatation.

Start date: June 12, 2018
Phase:
Study type: Observational

Study with the aim to see the effect on a space ground analogue , Hyper-Buoyancy Floatation (HBF) on lumbar column and the effect of a supplementary 50% of an axial load.

NCT ID: NCT05589116 Completed - Resilience Clinical Trials

An Online Compassionate Imagery Intervention for Veterinarian Mental Health

Start date: November 29, 2022
Phase: N/A
Study type: Interventional

This randomised control trial aims to determine the efficacy of a two-week, online compassionate imagery intervention on improving veterinarian mental wellbeing. Participants will be randomly allocated to receive the intervention immediately or after a 10-week study period. Self-report questionnaires will be used at four time points to measure change on a range of psychological variables.

NCT ID: NCT05585632 Completed - Influenza Clinical Trials

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Start date: October 14, 2022
Phase: Phase 1
Study type: Interventional

The primary goal of this study is to evaluate the safety and reactogenicity of multi-component vaccines mRNA-1045 (Influenza and RSV) and mRNA-1230 (influenza, RSV, and SARS-CoV-2) compared with mRNA-1010 (influenza), mRNA-1345 (RSV), and mRNA-1273.214 (SARS-CoV-2) vaccines in healthy older participants.